Dipeptidyl peptidase 4 (DPP-4) inhibitors for people with chronic kidney disease and diabetes.
Saved in:
| Title: | Dipeptidyl peptidase 4 (DPP-4) inhibitors for people with chronic kidney disease and diabetes. |
|---|---|
| Authors: | Natale P; Sydney School of Public Health, The University of Sydney, Sydney, Australia.; Department of Precision and Regenerative Medicine and Ionian Area (DIMEPRE-J), University of Bari Aldo Moro, Bari, Italy., Green SC; Department of Medicine, University of Otago Christchurch, Christchurch, New Zealand., Tunnicliffe DJ; Sydney School of Public Health, The University of Sydney, Sydney, Australia.; Centre for Kidney Research, The Children's Hospital at Westmead, Westmead, Australia., Pellegrino G; Department of Precision and Regenerative Medicine and Ionian Area (DIMEPRE-J), University of Bari Aldo Moro, Bari, Italy., Toyama T; Department of Nephrology, Faculty of Medical Sciences, University of Fukui, Fukui, Japan., Strippoli GF; Sydney School of Public Health, The University of Sydney, Sydney, Australia.; Department of Precision and Regenerative Medicine and Ionian Area (DIMEPRE-J), University of Bari Aldo Moro, Bari, Italy. |
| Corporate Authors: | supported by Cochrane Kidney and Transplant |
| Source: | The Cochrane database of systematic reviews [Cochrane Database Syst Rev] 2025 Nov 20; Vol. 11. Cochrane AN: CD015906. Date of Electronic Publication: 2025 Nov 20. |
| Publication Type: | Journal Article; Systematic Review; Meta-Analysis |
| Journal Info: | Publisher: Wiley Country of Publication: England NLM ID: 100909747 Publication Model: Electronic Cited Medium: Internet ISSN: 1469-493X (Electronic) Linking ISSN: 13616137 NLM ISO Abbreviation: Cochrane Database Syst Rev Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
